Columbia Care (NEO:CCHW) has received approval from the Puerto Rico Department of Health to begin operations in the capital, San Juan.
As quoted in the press release:
The Company’s +2,800 square foot San Juan dispensary, its first to open in the territory, has a design similar to its highly acclaimed Brooklyn and San Diego facilities, incorporating an inviting, modern look and feel that includes an open reception area, as well as a private consultation room that is consistent with the Company’s patient-centric, provider-based model. In this reserved space, extremely knowledgeable staff members will provide expert information and guidance to patients and caregivers about the dispensary’s offerings, including Columbia Care’s proprietary portfolio of cannabis-based medicines and a range of other carefully curated products that have met Columbia Care’s high testing standards.
“We are thrilled to join the Puerto Rican community and be a part of its economic revival. Columbia Care continues to execute its national rollout strategy with Puerto Rico representing our 11th market launch in the US and the fourth in the past 35 days (California, Florida, Ohio and Puerto Rico). To address the specific needs of Puerto Rico’s fast-growing market, Columbia Care is leveraging its extensive operational experience and know-how to bring differentiated products to market as quickly as possible, offering patients access to a high-quality portfolio of cannabis-based medicines and producing meaningful wholesale and retail revenue almost immediately,” said Nicholas Vita, chief executive officer of Columbia Care. “Patients at our San Juan dispensary will be able to choose from a variety of our well-known and trusted consumer oriented health and wellness products in addition to our portfolio of proprietary, precision dosed, pharmaceutical-quality medicines, all of which will be manufactured by our team of experts at our Cidra facility. In addition, Columbia Care will offer patients a carefully curated selection of third party products as well. To facilitate and optimize each person’s health and wellness journey, our market director, Nicole Quiles Alves, PharmD, will leverage her team of professionals to offer an unparalleled and completely unique level of personalized service and support.”
Numinus Bioscience adds Ketamine and LSD to licence to produce, assemble and sell a wide variety of psychedelic compounds
Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI ), a global leader in supporting and expanding the safe, accessible and evidence-based use of psychedelic-assisted psychotherapies (PAP), has received new amendments under Canada’s Controlled Drugs and Substances Act that enhance the Company’s ability to lead psychedelics research and support the global psychedelics sector.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.
For more information regarding the Company or the offering, please contact firstname.lastname@example.org, or
INDVR Brands Inc. Announces Asset Purchase Agreement with Strainz, Inc. and Bronnor, Corp., to Become a Fully Licensed Manufacturer and Distributor of Infused Products in Colorado
INDVR BRANDS INC. (CSE: IDVR) (the “Company” or “INDVR Brands” or “INDVR”), a premier cannabis brand consolidator and producer of Cannabis infused products is pleased to announce the following:
Definitive Asset Purchase Agreement with Strainz, Inc. and Bronnor, Corp.